A detailed history of Greenleaf Trust transactions in Incyte Corp stock. As of the latest transaction made, Greenleaf Trust holds 5,066 shares of INCY stock, worth $353,657. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,066
Previous 4,849 4.48%
Holding current value
$353,657
Previous $320,000 9.06%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

BUY
$65.08 - $83.38 $14,122 - $18,093
217 Added 4.48%
5,066 $349,000
Q3 2024

Oct 22, 2024

SELL
$57.33 - $68.61 $1,203 - $1,440
-21 Reduced 0.43%
4,849 $320,000
Q2 2024

Jul 22, 2024

BUY
$51.18 - $63.75 $249,246 - $310,462
4,870 New
4,870 $295,000
Q4 2022

Jan 25, 2023

BUY
$67.18 - $84.11 $180,243 - $225,667
2,683 New
2,683 $215,000
Q1 2018

Apr 30, 2018

SELL
$83.06 - $100.98 $10,880 - $13,228
-131 Closed
0 $0
Q3 2017

Nov 13, 2017

BUY
$109.15 - $138.27 $14,298 - $18,113
131
131 $15,000

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15.5B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Greenleaf Trust Portfolio

Follow Greenleaf Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.